Cargando…
Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
BACKGROUND: Infections acquired in hospital are an important cause of morbidity and mortality in very preterm infants. Several small trials have suggested that supplementing the enteral diet of very preterm infants with lactoferrin, an antimicrobial protein processed from cow's milk, prevents i...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356450/ https://www.ncbi.nlm.nih.gov/pubmed/30635141 http://dx.doi.org/10.1016/S0140-6736(18)32221-9 |
Ejemplares similares
-
Mechanisms affecting the gut of preterm infants in enteral feeding trials: a nested cohort within a randomised controlled trial of lactoferrin
por: Young, Greg, et al.
Publicado: (2023) -
Enteral Lactoferrin Supplementation for Preventing Sepsis and Necrotizing Enterocolitis in Preterm Infants: A Meta‑Analysis With Trial Sequential Analysis of Randomized Controlled Trials
por: Gao, Ya, et al.
Publicado: (2020) -
Randomized controlled trial of early arachidonic acid and docosahexaenoic acid enteral supplementation in very preterm infants
por: Álvarez, Patricia, et al.
Publicado: (2022) -
Lactoferrin infant feeding trial_Canada (LIFT_Canada): protocol for a randomized trial of adding lactoferrin to feeds of very-low-birth-weight preterm infants
por: Asztalos, Elizabeth V., et al.
Publicado: (2020) -
Protocol for the Lactoferrin Infant Feeding Trial (LIFT): a randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital discharge
por: Martin, Andrew, et al.
Publicado: (2018)